focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
just inserting into a decent thread ... in case anyone missed it...
"Avacta Group’s COVID-19 tests could hold the key to economic recovery"
"AIM-listed Avacta (LON:AVCT) is at the forefront of the drive to develop testing kits on a large enough scale to help track COVID-19 and prevent the spread of the virus, and ultimately reduce deaths.
The broad testing for COVID-19 is also the first step in allowing non-contagious people go back to work and aid the economic recovery."
https://ukinvestormagazine.co.uk/avacta-groups-covid-19-tests-could-hold-the-key-to-economic-recovery/?mc_cid=45d7a60b8a&mc_eid=562aaeb05f
no... but like any investor... US investors can buy UK stocks and many will be hunting down and researching credible Covid-19 plays. They can stay up all night for the UK open of course... but mostly wake up and start their day later in our day. You get that right ?
I doubt it ... more likely his account was terminated. I'm surprised it lasted as long as it did... you can't just set up new accounts purely to troll and disrupt forums for the sake of a petty delusional attempt to manipulate the market by influencing weak holders.
I noticed an FDA guy on the news last night talking about there being a lot of tests in the pipe but mentioning the supply of reagents and other essentials being the important element.
AVCT is like being hooked up with a major supermarket bakery to bake the best bread during a global bread shortage... at the same time as making the best flour for all other global bakeries.
It is also potential that is well ahead of schedule as we a have been informed ... "in only four weeks and well ahead of schedule, it has successfully generated multiple Affimer reagents that bind the SARS-COV-2 viral antigen"
But yes... Covid-19 test aside ... there is a lot more going on to back up the share price and many of us (Myles included of course) have been invested prior to any mention of Covid-19 testing for that very reason.
@igrowmoney ... You could start with this thread and post by Myles McNulty...
"There are a few new faces since I last posted here, so I thought I’d re-share my research on Avacta, for those who haven’t seen it.
Original investment thesis, 01/03/2020:
aimchaos.files.wordpress.com/2020/03/avacta-group-investment-thesis-3.pdf
Update note on the Company’s work on COVID-19 testing, 15/04/2020:
https://aimchaos.files.wordpress.com/2020/04/avacta-group-update.pdf
Frankly, I am astounded by the current share price. There seems to have been some concern about the placing shares hitting the market tomorrow – but there’s been no sell off since the GM results earlier so I think my suggestion on p.13 of my second note, about who the placees were, was correct. Any institutions who wanted to take some profits would likely have done so already, either by selling down their existing holdings (to then reload with the shares being issued tomorrow), or by selling their to-be-issued shares on extended settlement.
Whatever the case, it is largely irrelevant. The TVR is now 208m, and I can’t see that changing for the foreseeable. The Company has circa £11m net cash now, which is more than enough for global diagnostics players to be willing to collaborate.
The CEO could not have been clearer – there will be additional partnerships announced over the coming weeks. There will also be pre-orders of test in the millions by bodies such as PHE. I would also be surprised if there was not grant funding for Avacta, either from the UK gov of from a major charity such as the Gates Foundation.
If you read my research (esp. the bullet points on p.13 of my second note), all of these announcements should not come as a surprise, when they do come out. The wider market is however – in general – not well researched, and so will get excited and pile in when these announcements do steadily come one. The obvious move is, simply position in size before they do, and don’t be surprised WHEN they do.
I hold 2m shares at ~21p average, and don’t intend to sell any at all until we hit ~500p / ~£1bn mkt cap. My longer-term target is several billion pounds. The detailed rationale for this valuation is all in the first note. I am particularly excited by the TMAC platform, as I think it has the potential to generate drugs that will themselves generate tens of $billions in sales, each year.
Retrospectively, the main flaw of my research is underestimating just how many lateral flow tests that use Affimer-based reagents (Cytiva’s and those of other yet-to-be-named partners) could be sold globally. I estimated 1-3 billion per annum. Given the recent noise coming out of the US, I think it could be several multiples of my estimate."
no one is reporting anyone because they have an opposing point of view... market abuse, trolling and disrupting the BB is the issue. LSE is already poor enough without market abusing idiots like this being allowed to infect it without any moderation.
"Spain sends back faulty coronavirus tests made in China... which had been sent out to replace an earlier batch of faulty tests.
Spain forced to return second batch of 'faulty' coronavirus testing kits to China
Comes after they sent back 58,000 kits due to inaccuracy concerns last month
Spanish Health Ministry is now seeking a refund for entire order of 640,000 kits"
Gonna need some better tests.... globally.
"When we compared SARS-CoV-2 detection from patient-matched nasopharyngeal and saliva samples, we found that saliva yielded greater detection sensitivity and consistency throughout the course of infection. Furthermore, we report less variability in self-sample collection of saliva. Taken together, our findings demonstrate that saliva is a viable and more sensitive alternative to nasopharyngeal swabs and could enable at-home self-administered sample collection for accurate large-scale SARS-CoV-2 testing."
https://www.medrxiv.org/content/10.1101/2020.04.16.20067835v1
Jog on Redial, you are a stone cold snide liar... you had this to say after the news you say changed your mind immediately and your BS that you've now bought...
"You sell the news and the announcement of the collaboration has seen a huge rise and subsequent sell off. What I will say it lets wait and see what happens when the new shares are admitted to the existing circulation. I will dough my cap to you if I am wrong."
You talk about doing research when you come on here trolling and deramping talking about how useless "anibody" tests are when we are on an antigen test.
Some more of your gems...
"The reality here is 20 odd p is on the cards once the shares hit the market"
"When that happens the price will TANK"
"it's 100% accurate that if you dilute the company the price will go down"
"The price is much closer to 40p than 80p...it's only Monday. I did say 40p by Friday. it's getting there quick."
In case anyone missed it with all the broker pimps and trolls diluting the BB...
"AIM-listed Avacta (LON:AVCT) is at the forefront of the drive to develop testing kits on a large enough scale to help track COVID-19 and prevent the spread of the virus, and ultimately reduce deaths.
The broad testing for COVID-19 is also the first step in allowing non-contagious people go back to work and aid the economic recovery." ....
More ...
https://ukinvestormagazine.co.uk/avacta-groups-covid-19-tests-could-hold-the-key-to-economic-recovery/?mc_cid=45d7a60b8a&mc_eid=562aaeb05f
actually... saying that, I haven't worked it out lol.
Cavendish have plenty of headroom atm too.
"I am quite sure there a few posters doing it intentionally. It also has the added effect of crowding out any useful discussion about the company and its operations."
Exactly that Myles.
Rare to see this unfathomable level of goonery and numptyism on a bb. Bodes well.